HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshikazu Kinoshita Selected Research

Heartburn (Pyrosis)

11/2019Efficacy and Safety of Vonoprazan in Patients With Nonerosive Gastroesophageal Reflux Disease: A Randomized, Placebo-Controlled, Phase 3 Study.
6/2016Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
1/2016Evaluation of the Efficacy and Safety of Vonoprazan in Patients with Nonerosive Gastroesophageal Reflux Disease: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
7/2014Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito.
4/2014Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.
10/2013Generation of Gastroesophageal Reflux Disease Symptoms During Esophageal Acid Infusion With Concomitant Esophageal pH Monitoring in Healthy Adults.
5/2012Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
4/2012Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
2/2012Comparisons of symptoms reported by elderly and non-elderly patients with GERD.
8/2011Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshikazu Kinoshita Research Topics

Disease

40Gastroesophageal Reflux (GERD)
01/2022 - 03/2003
30Peptic Esophagitis (Reflux Esophagitis)
01/2022 - 12/2003
22Infections
06/2019 - 11/2002
19Inflammation (Inflammations)
04/2022 - 05/2005
18Heartburn (Pyrosis)
11/2019 - 12/2003
17Neoplasms (Cancer)
01/2016 - 07/2002
15Non-Erosive Reflux Disease
01/2022 - 05/2007
15Colitis
01/2021 - 10/2002
14Ulcer
04/2018 - 08/2002
13Eosinophilic Esophagitis
10/2021 - 01/2012
11Hemorrhage
01/2018 - 08/2002
10Barrett Esophagus (Barrett's Esophagus)
03/2016 - 01/2004
9Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
10/2021 - 08/2013
8Diarrhea
04/2022 - 06/2012
7Ulcerative Colitis
04/2020 - 01/2012
7Atrophy
07/2019 - 12/2003
7Peptic Ulcer (Peptic Ulcers)
07/2015 - 08/2002
6Eosinophilic enteropathy
04/2022 - 01/2012
6Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 10/2002
6Constipation
09/2019 - 02/2016
6Crohn Disease (Crohn's Disease)
01/2019 - 01/2013
6Eosinophilia
05/2018 - 07/2006
6Dyspepsia (Indigestion)
04/2018 - 04/2006
6Carcinogenesis
08/2015 - 07/2004
5Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
12/2018 - 07/2015
5Stomach Ulcer (Gastric Ulcer)
04/2018 - 01/2006
5Hepatocellular Carcinoma (Hepatoma)
01/2018 - 09/2006
5Esophagitis
01/2018 - 02/2005
5Hiatal Hernia
03/2017 - 08/2006
4Pneumonia (Pneumonitis)
04/2022 - 12/2009
4Pathologic Constriction (Stenosis)
12/2021 - 09/2015
4Abdominal Pain (Pain, Abdominal)
12/2018 - 06/2008
4Gastritis
04/2018 - 07/2004
4Liver Diseases (Liver Disease)
11/2017 - 01/2009
4Duodenal Ulcer (Curling's Ulcer)
08/2016 - 05/2002
4Body Weight (Weight, Body)
07/2013 - 02/2008
4Adenocarcinoma
11/2011 - 04/2002
4Chronic Hepatitis C
01/2010 - 01/2003
3Amyloidosis
04/2022 - 01/2013
3Celiac Disease (Celiac Sprue)
04/2022 - 02/2018
3Pancreatitis
12/2021 - 06/2006
3Chest Pain (Chest Pains)
11/2019 - 06/2008
3Hypersensitivity (Allergy)
01/2018 - 08/2013
3Pain (Aches)
01/2011 - 11/2008
3Stomach Neoplasms (Stomach Cancer)
05/2005 - 10/2002

Drug/Important Bio-Agent (IBA)

45Proton Pump InhibitorsIBA
01/2021 - 08/2002
34AcidsIBA
01/2022 - 03/2003
19Pharmaceutical PreparationsIBA
01/2021 - 12/2008
16Proteins (Proteins, Gene)FDA Link
01/2018 - 10/2002
13Rabeprazole (Aciphex)FDA Link
07/2018 - 01/2003
11Famotidine (Pepcid)FDA LinkGeneric
01/2017 - 02/2003
10CytokinesIBA
10/2021 - 10/2002
10Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2018 - 08/2005
9Lansoprazole (Prevacid)FDA LinkGeneric
06/2016 - 02/2003
8Omeprazole (Prilosec)FDA LinkGeneric
06/2014 - 12/2003
71- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
01/2022 - 01/2016
7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2018 - 08/2005
6Bile Acids and Salts (Bile Acids)IBA
04/2022 - 01/2007
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
08/2016 - 10/2002
6Dextrans (Dextran)FDA Link
08/2016 - 10/2002
6Therapeutic UsesIBA
06/2014 - 02/2005
5Leukocyte L1 Antigen Complex (Calgranulin)IBA
05/2019 - 01/2014
5LipidsIBA
11/2018 - 07/2004
5Esomeprazole (Nexium)FDA Link
05/2018 - 02/2013
4AllergensIBA
10/2019 - 08/2013
4Biomarkers (Surrogate Marker)IBA
05/2019 - 11/2017
4Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 01/2009
4LigandsIBA
11/2017 - 07/2002
4liu-jun-zi-tangIBA
08/2016 - 04/2012
4Histamine H2 AntagonistsIBA
01/2016 - 03/2003
4milk fat globuleIBA
08/2015 - 01/2012
4MucinsIBA
09/2011 - 08/2006
3GlucocorticoidsIBA
04/2022 - 06/2011
3PotassiumIBA
01/2022 - 01/2016
3Dextran SulfateIBA
01/2020 - 10/2006
3Urea (Carbamide)FDA LinkGeneric
06/2019 - 02/2003
3Z 338IBA
01/2019 - 09/2015
3Hemoglobins (Hemoglobin)IBA
01/2019 - 01/2016
3linaclotideIBA
01/2019 - 12/2018
3Chemokine CCL26IBA
01/2018 - 01/2016
3Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2018 - 01/2017
3InterleukinsIBA
11/2017 - 03/2012
3Histamine (Histamine Dihydrochloride)FDA Link
08/2016 - 01/2008
3lafutidineIBA
06/2016 - 04/2010
3Acetic Acid (Vinegar)FDA LinkGeneric
01/2016 - 03/2004
3Epidermal Growth Factor (EGF)IBA
08/2015 - 01/2012
3Gentian Violet (Violet, Crystal)FDA Link
04/2015 - 01/2004
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2015 - 06/2007
3Interleukin-10 (Interleukin 10)IBA
12/2014 - 12/2010
3Reactive Oxygen Species (Oxygen Radicals)IBA
12/2014 - 09/2006
3Toll-Like Receptors (Toll-Like Receptor)IBA
11/2013 - 04/2003
3SolutionsIBA
10/2013 - 06/2008
3rebamipideIBA
06/2012 - 02/2003
3Messenger RNA (mRNA)IBA
09/2011 - 03/2004
3InterferonsIBA
01/2010 - 01/2003
3Drinking WaterIBA
06/2008 - 10/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2008 - 10/2002

Therapy/Procedure

37Therapeutics
10/2021 - 01/2002
4Gastrostomy
10/2013 - 12/2009
3Drug Therapy (Chemotherapy)
11/2010 - 02/2008